$EVGN

Evogene Ltd. (EVGN): Financial results for Q2 2026

Evogene Ltd. (EVGN) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Evogene Reports Second Quarter and First Half 2026 Financial Results · Company continues strategic transformation, initiated in 2025, into a focused, AI-driven computational chemistry company, with significant progress across pharmaceutical and agricultural product d

Original reporting
Published Aug 18, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 6:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$EVGN
Bullish
high confidence
Mentioned
$EVGN
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$EVGNBullishMed
01

Why it matters

The earnings release provides the first public numbers for Q2 2026, offering fresh data for valuation and risk assessment.

02

Market read

First‑report earnings for a micro‑cap AI chemistry firm; may influence short‑term trading and sector sentiment.

03

What to watch

Recent divestitures and discontinued operations could mask underlying execution risks.

Relevance 7/10Novelty 7/10Timing: filed today (Aug 18, 2026)

Background

Evogene is transitioning to an AI‑driven computational chemistry model, cutting staff and focusing on pharma and agri programs.

Company-level read

Ticker impact

$EVGNBullishHigh confidence
Context

Evogene reported Q2 2026 results, showing reduced net loss and lower cash burn, plus new AI-driven collaborations.

Expected impact

moderate upside as investors reassess cash runway and AI progress

Evidence & confidence

Reduced loss and cash burn indicate operational turnaround; new collaborations suggest future revenue streams.

Market effects

Highlights growing AI adoption in computational chemistry, may boost sector sentiment for biotech AI tools.

Positive for Israeli tech ecosystem and Nasdaq-listed AI‑focused small caps.

Limited to niche AI‑driven chemistry space; no broad market impact.

Counterpoint

Cash burn remains high relative to revenue potential; investors may remain cautious.

Key entities

  • Ofer Haviv

    President and CEO of Evogene, quoted on transformation progress.

  • Nir Nimrodi

    Chairman of Evogene's Board, commented on Q2 performance.

Related articles

$SAMMed

Boston Beer (SAM) Q3 2026 Earnings Call Transcript

Boston Beer (SAM) reported Q3 2026 earnings, highlighting a 90-basis-point gross margin increase to 51.7% and $80M in share repurchases. Sun Cruiser grew 60%, while Angry Orchard saw consecutive quarter growth. Full-year guidance was narrowed, with depletions and shipments expected to decline mid-single digits. The company raised gross margin and EPS guidance despite elevated freight costs.

$WDCHighAI 8/10

Western Digital Delivers Better-Than-Expected Earnings, Stock Hit by After-Hours Selling

Western Digital (WDC) reported Q1 FY2027 earnings of $4.64 per share, beating expectations, with revenue up 55% YoY to $4.38B. Despite strong results, shares fell 6.43% during trading and 6% after-hours due to concerns over rising capital expenditure and financing conditions. CEO Irving Tan cited stable demand and efficient execution as growth drivers. The company raised its quarterly dividend and provided optimistic guidance for Q2.

$WDCHighAI 9/10

WDC (WDC) Q1 2027 Earnings Call Transcript

WDC reported Q1 2027 revenue of $4.4B, up 55% YoY, driven by strong demand for high-capacity data storage solutions. The company shipped 248 exabytes, up 22% YoY, and expects revenue to grow to $5.1B in Q2 2027. WDC is transitioning customers to higher capacity drives and plans to begin volume shipments of its HAMR technology in early 2027. The company also increased its quarterly dividend by 17%.

$DECKHighAI 8/10

Deckers (DECK) Q2 2027 Earnings Call Transcript

Deckers (DECK) reported Q2 2027 revenue growth of 3.5%, with HOKA and UGG up 7% and 4% respectively. EPS was $2.31, including a $0.28 tariff benefit, or $2.03 excluding it, exceeding guidance. The company maintained healthy margins and updated its fiscal year outlook to reflect measured growth due to economic pressures. International markets, particularly APAC, showed strength, while U.S. e-commerce faced challenges due to promotional activity.

$OMCHighAI 9/10

Omnicom (OMC) Q3 2026 Earnings Call Transcript

Omnicom (OMC) reported Q3 2026 earnings, highlighting 7.3% revenue growth and 21.1% adjusted EBITDA increase. The company secured new clients and extended contracts, including a 5-year deal with AWS. Omnicom expects $900M in cost reduction synergies and completed $3.2B of a $5B share repurchase plan. Adjusted EPS grew 22% to $2.73, driven by net income growth. The company is integrating Interpublic and investing in AI and technology.